| value |
{"aggregator_url":"https://www.nasdaq. {"aggregator_url":"https://www.nasdaq.com/articles/market-crash-2-healthcare-stocks-worth-loading-discount","as_of":"2026-04-20T10:08:18.324557+00:00","canonical_url":"https://www.fool.com/investing/2026/04/20/market-crash-2-healthcare-stocks-worth-loading-up/","enrichment":{"aggregator_url":"https://www.nasdaq.com/articles/market-crash-2-healthcare-stocks-worth-loading-discount","article_chars":5000,"article_truncated":true,"blocked_reason":null,"candidate_id":"sc_adc1194148bb5d49","canonical_host":"fool.com","canonical_is_aggregator":false,"canonical_url":"https://www.fool.com/investing/2026/04/20/market-crash-2-healthcare-stocks-worth-loading-up/","content_type":"text/html; charset=utf-8","enriched_at":"2026-04-20T10:09:57.210141+00:00","extraction_method":"trafilatura","fetched_description":"Key PointsThese healthcare stocks offer long track records of solid performance.","fetched_title":"Market Crash: 2 Healthcare Stocks Worth Loading Up on at a Discount | Nasdaq","final_url":"https://www.nasdaq.com/articles/market-crash-2-healthcare-stocks-worth-loading-discount","html_truncated":false,"paywall_likely":false,"publisher_domain":"fool.com","publisher_resolution":"canonical_url","requested_url":"https://www.nasdaq.com/articles/market-crash-2-healthcare-stocks-worth-loading-discount","source_event_id":"evt_3bbb4a0545a2","source_quality":"high","status_code":200,"version":"signal_enrichment_v2"},"fp":"bfa2d0a3299452c8","kind":"unusual_volume","published_at":"2026-04-20T09:28:00+00:00","publisher_domain":"fool.com","signal_understanding":{"analysis_basis":"article","claim_confidence":0.62,"dates_mentioned":["earlier this year","past few months","recent days","early 2026","December 17, 2004"],"entities":[{"asset_class":"equity","name":"Intuitive Surgical","relevance":"high","symbol":"ISRG","type":"company"},{"asset_class":"equity","name":"Abbott Laboratories","relevance":"high","symbol":"ABT","type":"company"},{"asset_class":"index","name":"S&P 500","relevance":"medium","symbol":"","type":"index"}],"event_type":"price_action","information_gaps":["No unusual trading volume ratio vs average is provided (baseline volume, volume ratio, and direction are missing).","The signal type suggests unusual volume, but the article text provided does not mention volume spikes or confirm them with any news.","The article provides a general market-turmoil context as the likely driver of declines, but does not explicitly link any volume change to a specific catalyst for ISRG or ABT.","No explicit catalyst hypothesis for unusual volume is stated; only valuation discount and macro/market concerns are discussed."],"key_facts":["The article states the stock market was volatile over the past few months, with the S&P 500 shifting from gains to losses, and that investors worried about the economy, the pace of interest rate cuts, and conflict in Iran.","The article says concerns grew about companies' investments in AI and whether future revenue will justify those levels.","The article claims that even though the market rebounded and the S&P 500 reached a new high, many stocks remain lower and at \u201cinteresting valuation levels.\u201d","For Intuitive Surgical (ISRG), the article states revenue increased 19% and Da Vinci procedures climbed 17% in the recent quarter.","For ISRG, the article states it is trading at 45x forward earnings estimates, down from 60x earlier this year.","For Abbott Laboratories (ABT), the article states the stock is trading at 17x forward earnings estimates, down from more than 22x in the early days of 2026.","For ABT, the article states it is a \u201cDividend King\u201d with dividend increases for at least 50 consecutive years."],"numeric_claims":[{"label":"ISRG forward P/E (current)","value":"45x"},{"label":"ISRG forward P/E (earlier this year)","value":"60x"},{"label":"ISRG revenue growth (recent quarter)","value":"19%"},{"label":"ISRG Da Vinci procedure growth (recent quarter)","value":"17%"},{"label":"ABT forward P/E (current)","value":"17x"},{"label":"ABT forward P/E (early 2026)","value":">22x"},{"label":"ABT dividend increase streak","value":"at least 50 consecutive years"}],"primary_claim":"ISRG and ABT declined with the general market and are now offered at valuation discounts (ISRG ~45x forward earnings vs 60x earlier this year; ABT ~17x forward earnings vs >22x in early 2026), making them attractive long-term purchases.","relevance_score":0.35,"sentiment":"mixed","source_quality":"high","summary":"The article argues that two healthcare stocks\u2014Intuitive Surgical (ISRG) and Abbott Laboratories (ABT)\u2014are trading at discounts after recent market turmoil and are positioned as long-term buys. It does not provide any specific unusual trading volume ratio or confirm a volume spike with news.","topics":["healthcare stocks","market turmoil","valuation discounts","robotic surgery","dividend growth","AI investment concerns","interest rate cuts","Iran conflict"]},"source":"Nasdaq Markets","source_domain":"fool.com","summary":"Key PointsThese healthcare stocks offer long track records of solid performance.","tickers":[],"title":"Market Crash: 2 Healthcare Stocks Worth Loading Up on at a Discount","url":"https://www.fool.com/investing/2026/04/20/market-crash-2-healthcare-stocks-worth-loading-up/"}... |